Correction to: Regulating Human Embryonic Stem Cell in China
- PDF / 2,285,692 Bytes
- 215 Pages / 453.543 x 683.15 pts Page_size
- 101 Downloads / 191 Views
Regulating Human Embryonic Stem Cell in China A Comparative Study on Human Embryonic Stem Cell’s Patentability and Morality in US and EU
Regulating Human Embryonic Stem Cell in China
Li Jiang
Regulating Human Embryonic Stem Cell in China A Comparative Study on Human Embryonic Stem Cell’s Patentability and Morality in US and EU
123
Li Jiang Kenneth Wang School of Law Soochow University Suzhou, Jiangsu People’s Republic of China
ISBN 978-981-10-2100-8 DOI 10.1007/978-981-10-2101-5
ISBN 978-981-10-2101-5
(eBook)
Library of Congress Control Number: 2016946298 © Springer Science+Business Media Singapore 2016 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The publisher, the authors and the editors are safe to assume that the advice and information in this book are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty, express or implied, with respect to the material contained herein or for any errors or omissions that may have been made. Printed on acid-free paper This Springer imprint is published by Springer Nature The registered company is Springer Science+Business Media Singapore Pte Ltd.
Preface
Two of the seven sins identified by Mahatma Gandhi are “commerce without morality” and “science without humanity”. It warns people to moderate science and business for the benefit of humanity. In Human Embryonic Stem Cell (HESC) field, a need to reconstruct the stem cell regulation framework to reconcile scientific development and human health confronts the citizens of China. HESC holds the promise of treating many incurable diseases such as cancer, diabetes and Parkinson’s disease; however, the interplay between patent law and moral controversy has generated enormous variations in addition to the jurisdiction complexities. The diversity of HESC regulation has been considered problematic, since varied regulations in states might impede research collaboration and scientific advance. Researchers working across jurisdictions are required to meet different technical, ethical and legal standards. Some developing countries have sought to profit from the regulatory vacuum. Such a situation can be seen in China where unproven and unsafe stem cell therapies are currently offered to patients. While attempts have been made to examine the disparities in HESC regulations ac
Data Loading...
